Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

How would Anavex be able to sell Blarcamesine for $3,650 a year ($10 a day) for AD and $200,000-$600,000 a year for Rett? Please provide any example where the identical approved marketed drug is priced so low for one indication and so high for another.